Xiaflex: Phase III data

Top-line data from the double-blind, international Phase III IMPRESS I trial in 417 patients with Peyronie's disease showed that twice-weekly Xiaflex every 6 weeks for up to 4 treatment cycles followed by a penile modeling procedure met the co-primary endpoints of reducing penile curvature deformity and improving PDQ bother domain

Read the full 501 word article

User Sign In